Prospective study of wide excision and endocrine therapy WithOut RadioTHerapy (WORTH) for node-negative estrogen receptor positive early breast cancer with histologically negative margins (WORTH trial)(No.4)
Phase 2
- Conditions
- early breast cancer
- Registration Number
- JPRN-UMIN000000536
- Lead Sponsor
- a Grant-in-Aid for research of cancer treatment from the Ministry of Health, Labor and Welfare of Japan (No.21-7-4)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. multicentricity of the tumor is suspected 2. past history of breast cancer or synchronous bilateral breast cancer 3. trastuzumab treatment is planned 4. the patient has mental disorder 5. any reason the physician believes that the patient is not appropriate to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In-breast recurrence rate
- Secondary Outcome Measures
Name Time Method